ES2059537T3 - Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina. - Google Patents
Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina.Info
- Publication number
- ES2059537T3 ES2059537T3 ES88310432T ES88310432T ES2059537T3 ES 2059537 T3 ES2059537 T3 ES 2059537T3 ES 88310432 T ES88310432 T ES 88310432T ES 88310432 T ES88310432 T ES 88310432T ES 2059537 T3 ES2059537 T3 ES 2059537T3
- Authority
- ES
- Spain
- Prior art keywords
- lymphocine
- purging
- aid
- residual tumor
- tumor cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0093—Purging against cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
SE PRESENTA UN METODO PARA ELIMINAR CELULAS TUMORALES RESIDUALES DE UN PACIENTE CON UNA ALTERACION NEOPLASICA TRATANDO IN VITRO UNA PREPARACION CELULAR CON CELULAS CITOTOXICAS ACTIVADAS CON LINFOQUINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/120,299 US5041289A (en) | 1987-11-13 | 1987-11-13 | Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2059537T3 true ES2059537T3 (es) | 1994-11-16 |
Family
ID=22389429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88310432T Expired - Lifetime ES2059537T3 (es) | 1987-11-13 | 1988-11-07 | Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5041289A (es) |
EP (1) | EP0317141B1 (es) |
JP (1) | JPH022345A (es) |
AT (1) | ATE108659T1 (es) |
DE (1) | DE3850745T2 (es) |
ES (1) | ES2059537T3 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0494268B2 (en) * | 1989-09-25 | 1999-04-28 | Genetics Institute, Inc. | Method for inhibiting growth of stem cells |
US5728388A (en) * | 1989-10-03 | 1998-03-17 | Terman; David S. | Method of cancer treatment |
US5229115A (en) * | 1990-07-26 | 1993-07-20 | Immunex Corporation | Adoptive immunotherapy with interleukin-7 |
US5814295A (en) * | 1992-04-10 | 1998-09-29 | The Ohio State University Research Foundation | Determination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapy |
AU6358994A (en) * | 1993-03-02 | 1994-09-26 | David S. Terman | Method of cancer treatment |
US6093381A (en) * | 1994-07-13 | 2000-07-25 | Neoprobe Corporation | Modulation of the sensitivity of tumor cells to chemotherapeutics |
US20020182730A1 (en) * | 1995-07-26 | 2002-12-05 | Micheal L. Gruenberg | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
US6630305B1 (en) | 1999-11-12 | 2003-10-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6800746B2 (en) | 1997-02-25 | 2004-10-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6894146B1 (en) | 1997-02-25 | 2005-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6620922B1 (en) | 1997-02-25 | 2003-09-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7033827B2 (en) | 1997-02-25 | 2006-04-25 | Corixa Corporation | Prostate-specific polynucleotide compositions |
US6943236B2 (en) | 1997-02-25 | 2005-09-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
TR199902053T2 (xx) | 1997-02-25 | 2000-04-21 | Corixa Corporation | Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar. |
US6465611B1 (en) | 1997-02-25 | 2002-10-15 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6329505B1 (en) | 1997-02-25 | 2001-12-11 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6261562B1 (en) | 1997-02-25 | 2001-07-17 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US6818751B1 (en) | 1997-08-01 | 2004-11-16 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6613872B1 (en) | 1997-02-25 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy of prostate cancer and methods for their use |
US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6395278B1 (en) | 1997-02-25 | 2002-05-28 | Corixa Corporation | Prostate specific fusion protein compositions |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US6623923B1 (en) | 1998-12-23 | 2003-09-23 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
CZ2001149A3 (cs) * | 1998-07-14 | 2002-02-13 | Corixa Corporation | Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty |
AU7994200A (en) * | 1999-10-04 | 2001-05-10 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
JP2004537252A (ja) * | 1999-11-12 | 2004-12-16 | コリクサ コーポレイション | 前立腺癌の治療及び診断のための組成物及び方法 |
EP1242598A2 (en) * | 1999-12-30 | 2002-09-25 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US7048931B1 (en) | 2000-11-09 | 2006-05-23 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
FR2821947B1 (fr) * | 2001-03-12 | 2003-05-16 | Canon Kk | Procede et dispositif de validation de parametres definissant une image |
US20030134415A1 (en) * | 2001-09-19 | 2003-07-17 | Gruenberg Micheal L. | Th1 cell adoptive immunotherapy |
US20030134341A1 (en) * | 2001-09-19 | 2003-07-17 | Medcell Biologics, Llc. | Th1 cell adoptive immunotherapy |
US20030175272A1 (en) * | 2002-03-07 | 2003-09-18 | Medcell Biologics, Inc. | Re-activated T-cells for adoptive immunotherapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4714680B1 (en) * | 1984-02-06 | 1995-06-27 | Univ Johns Hopkins | Human stem cells |
US4604377A (en) * | 1984-03-28 | 1986-08-05 | Cetus Corporation | Pharmaceutical compositions of microbially produced interleukin-2 |
US4690915A (en) * | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
-
1987
- 1987-11-13 US US07/120,299 patent/US5041289A/en not_active Expired - Fee Related
-
1988
- 1988-11-07 EP EP88310432A patent/EP0317141B1/en not_active Expired - Lifetime
- 1988-11-07 ES ES88310432T patent/ES2059537T3/es not_active Expired - Lifetime
- 1988-11-07 DE DE3850745T patent/DE3850745T2/de not_active Expired - Fee Related
- 1988-11-07 AT AT88310432T patent/ATE108659T1/de not_active IP Right Cessation
- 1988-11-14 JP JP63287507A patent/JPH022345A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0317141A3 (en) | 1990-04-04 |
US5041289A (en) | 1991-08-20 |
EP0317141B1 (en) | 1994-07-20 |
ATE108659T1 (de) | 1994-08-15 |
DE3850745T2 (de) | 1994-11-24 |
JPH022345A (ja) | 1990-01-08 |
DE3850745D1 (de) | 1994-08-25 |
EP0317141A2 (en) | 1989-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059537T3 (es) | Metodo para purgar in vitro celulas tumorales residuales con la ayuda de celulas citotoxicas activadas por una linfocina. | |
AU588806B2 (en) | Drug, and methods of preparing and using it for treatment of tumors | |
AU2982889A (en) | Novel dosage form of fenofibrate | |
ES2027013T3 (es) | Un procedimiento para preparar una forma de dosificacion de liberacion controlada. | |
SE8504720D0 (sv) | New drug preparation | |
FI882044A (fi) | Orala doseringsformer med foerdroejd frigivning. | |
ES2010648T3 (es) | Formulaciones farmaceuticas de sustancias labiles frente a los acidos para uso oral. | |
ES2060399T3 (es) | Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento. | |
ES527077A0 (es) | Procedimiento para la produccion de una hormona de crecimiento de porcino. | |
CA990165A (en) | Implant for directed infusion of biologically active substances, a method for its producing and a mold for carrying out said method | |
SE8701004D0 (sv) | Method for therapy of leukemias and certain other malignancies | |
FR2253494A1 (es) | ||
EP0202642A3 (en) | Process for the in vitro immunization of human splenocytes against tumor associated antigens | |
JPS5686194A (en) | Novel protein and its manufacture | |
HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
ES544939A0 (es) | Procedimiento para la realizacion de una pieza injertable por via quirurgica dentro de un organismo y pieza obtenida con dicho procedimiento | |
FR2389625A1 (es) | ||
FR2393565A1 (fr) | Procede et dispositif de fixation amovible de protheses, notamment de protheses dentaires | |
ES2061722T3 (es) | Derivados de fenantridina, procedimiento para su obtencion y agentes para la realizacion del procedimiento. | |
ZA885625B (en) | Therapeutic agents containing enantiomers of propafenone | |
AR243231A1 (es) | Procedimiento para producir medios de cultivo. | |
AU3942472A (en) | Implant for surgical purposes andthe method for its producing | |
GR3001809T3 (en) | Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments | |
AR224929Q (es) | Procedimiento para la preparacion de formas medicamentosas administrable por via oral,de liberacion uniforme e independiente del ph de una sustancia activa soluble en agua | |
EP0302799A3 (en) | Process for the preparation of l,l or d,d or racemic n6-benzyloxycarbonyl-2,6-diamino-pimelamic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 317141 Country of ref document: ES |